AmunBio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

AmunBio General Information

Description

Operator of a biotechnology company intended to develop next-generation immunotherapies for cancer treatment. The company offers engineered oncolytic viruses that selectively replicate in tumor cells, block immune suppression, and stimulate cancer-fighting immune responses, enabling healthcare providers to treat various cancers with targeted and effective immuno-oncology therapies.

Contact Information

Website
www.amunbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Seattle, WA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Seattle, WA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmunBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jul-2021 Completed Pre-Clinical Trials
To view AmunBio’s complete valuation and funding history, request access »

AmunBio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
3rdEyeBio Accelerator/Incubator Minority
To view AmunBio’s complete investors history, request access »

AmunBio FAQs

  • When was AmunBio founded?

    AmunBio was founded in 2020.

  • Where is AmunBio headquartered?

    AmunBio is headquartered in Seattle, WA.

  • What industry is AmunBio in?

    AmunBio’s primary industry is Drug Discovery.

  • Is AmunBio a private or public company?

    AmunBio is a Private company.

  • What is AmunBio’s current revenue?

    The current revenue for AmunBio is .

  • Who are AmunBio’s investors?

    3rdEyeBio has invested in AmunBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process